The report covers forecast and analysis for the Gallbladder Treatment market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the Gallbladder Treatment market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Gallbladder Treatment market on a global level. In order to give the users of this report a comprehensive view on the Gallbladder Treatment market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein disease indications, diagnosis, treatment, end users, and regional segments are benchmarked based on their market size, growth rate and general attractiveness.
The gall bladder is a tiny pear-shaped situated below the liver. Its primary role is to hold the bile produced by liver and allow transfer of it along through a duct that discharges into the small intestine. Gall bladder disorders affect a large number of people around the world. Gall bladder disorders impact a significant number of people around the globe. Gall bladder and associated biliary diseases arose in approximately 104 million people (1.6 percent) in 2016 and culminated in 106,000 deaths. Growing geriatric population, growing the prevalence rate of various gallbladder diseases, and developing and embracing innovative diagnostic treatment options are the major drivers for market development. In addition, growing awareness of the diseases, increasing healthcare spending and rising demand from Asia's emerging markets have fuelled market growth. Nevertheless, discomfort and health risks during operation and the symptomless nature of gall stones can delay market growth.
The study provides a decisive view on the Gallbladder Treatment market by segmenting the market based on disease indications, diagnosis, treatment, end users, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2020 to 2026. Based on disease indications, the market is segmented into gallstones, cholecystitis and biliary colic, cholelithiasis and choledocholithiasis, gallbladder polyps, gall bladder cancer.
Based on diagnosis, the market is segmented into ultrasound, blood tests, computerized tomography (CT), cholangiography and hepatobiliary scintigraphy.. Based on treatment, the market is segmented into surgery, and drugs. Based on end users, the market is segmented into hospitals & gynecology clinics, Academic & Research Centers. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Geographically speaking, North America dominated the gallbladder treatment market. Large gallbladder treatment patient pool, availability of developed infrastructure, growing awareness and presence of key players has led to increased demand for gallbladder treatment.
Growing geriatric population, growing the prevalence rate of various gallbladder diseases, and developing and embracing innovative diagnostic treatment options is accelerating the growth of the demand for gallbladder treatment. In addition, the increase in lifestyle spending as well as growing people's awareness drives the growth of the market for gallbladder treatment. However, discomfort and health risks during operation and the symptomless nature of gall stones may hamper the growth of the market for gallbladder treatment.
Key players within global Gallbladder Treatment market include Boston Scientific Corporation, Intuitive Surgical, C. R. Bard, Inc., Dornier MedTech, Koninklijke Philips N.V., B. Braun Melsungen AG, Sanofi and others others.
The report segments global Gallbladder Treatment market as follows:
Global Gallbladder Treatment Market: Disease Indications Segment Analysis
Global Gallbladder Treatment Market: Diagnosis Segment Analysis
Global Gallbladder Treatment Market: By Treatment Segment Analysis
Global Gallbladder Treatment Market: End Users Segment Analysis
Global Gallbladder Treatment Market: Regional Segment Analysis
The gall bladder is a tiny pear-shaped situated below the liver. Its primary role is to hold the bile produced by liver and allow transfer of it along through a duct that discharges into the small intestine. Gall bladder disorders affect a large number of people around the world. Gall bladder disorders impact a significant number of people around the globe. Gall bladder and associated biliary diseases arose in approximately 104 million people (1.6 percent) in 2016 and culminated in 106,000 deaths. Growing geriatric population, growing the prevalence rate of various gallbladder diseases, and developing and embracing innovative diagnostic treatment options are the major drivers for market development. In addition, growing awareness of the diseases, increasing healthcare spending and rising demand from Asia's emerging markets have fuelled market growth. Nevertheless, discomfort and health risks during operation and the symptomless nature of gall stones can delay market growth.
The study provides a decisive view on the Gallbladder Treatment market by segmenting the market based on disease indications, diagnosis, treatment, end users, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2020 to 2026. Based on disease indications, the market is segmented into gallstones, cholecystitis and biliary colic, cholelithiasis and choledocholithiasis, gallbladder polyps, gall bladder cancer.
Based on diagnosis, the market is segmented into ultrasound, blood tests, computerized tomography (CT), cholangiography and hepatobiliary scintigraphy.. Based on treatment, the market is segmented into surgery, and drugs. Based on end users, the market is segmented into hospitals & gynecology clinics, Academic & Research Centers. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Geographically speaking, North America dominated the gallbladder treatment market. Large gallbladder treatment patient pool, availability of developed infrastructure, growing awareness and presence of key players has led to increased demand for gallbladder treatment.
Growing geriatric population, growing the prevalence rate of various gallbladder diseases, and developing and embracing innovative diagnostic treatment options is accelerating the growth of the demand for gallbladder treatment. In addition, the increase in lifestyle spending as well as growing people's awareness drives the growth of the market for gallbladder treatment. However, discomfort and health risks during operation and the symptomless nature of gall stones may hamper the growth of the market for gallbladder treatment.
Key players within global Gallbladder Treatment market include Boston Scientific Corporation, Intuitive Surgical, C. R. Bard, Inc., Dornier MedTech, Koninklijke Philips N.V., B. Braun Melsungen AG, Sanofi and others others.
The report segments global Gallbladder Treatment market as follows:
Global Gallbladder Treatment Market: Disease Indications Segment Analysis
- Gallstones
- Cholecystitis And Biliary Colic
- Cholelithiasis And Choledocholithiasis
- Gallbladder Polyps
- Gall Bladder Cancer
Global Gallbladder Treatment Market: Diagnosis Segment Analysis
- Ultrasound
- Blood Tests
- Computerized Tomography (CT)
- Cholangiography
- Hepatobiliary Scintigraphy
Global Gallbladder Treatment Market: By Treatment Segment Analysis
- Surgery
- Drugs
Global Gallbladder Treatment Market: End Users Segment Analysis
- Hospitals & Gynecology Clinics
- Academic & Research Centers
Global Gallbladder Treatment Market: Regional Segment Analysis
- North America
- The U.S.
- Canada
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Table of Contents
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Gallbladder Treatment Market, 2016 - 2026, (USD Billion)
- 2.2. Gallbladder Treatment Market: Snapshot
- Chapter 3. Global Gallbladder Treatment Market – Industry Analysis
- 3.1. Gallbladder Treatment Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Growing the prevalence rate of various gallbladder diseases
- 3.2.2. Increased geriatric population
- 3.2.3. Developing And Embracing Innovative Diagnostic Treatment Options
- 3.2.4. Increasing Healthcare Spending
- 3.3. Restraints
- 3.3.1. Discomfort And Health Risks During Operation
- 3.3.2. Symptomless Nature Of Gall Stones
- 3.4. Opportunity
- 3.4.1. Economic growth paired by continuously growing medical expenditure
- 3.5. Porter’s Five Forces Analysis
- 3.6. Market Attractiveness Analysis
- 3.6.1. Market attractiveness analysis by disease indications segment
- 3.6.2. Market attractiveness analysis by diagnosis
- 3.6.3. Market attractiveness analysis by treatment segment
- 3.6.4. Market attractiveness analysis by end users segment
- 3.6.5. Market attractiveness analysis by regional segment
- Chapter 4. Global Gallbladder Treatment Market - Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Gallbladder Treatment market: company market share analysis, 2018
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New disease indications type launches
- 4.2.3. Agreements, partnerships, collaborations and joint ventures
- 4.2.4. Research and development and regional expansion
- 4.1. Company market share analysis
- Chapter 5. Global Gallbladder Treatment Market – Disease Indications Type Segment Analysis
- 5.1. Global Gallbladder Treatment market overview: by disease indications type
- 5.1.1. Global Gallbladder Treatment market revenue share, by disease indications type, 2019 and 2026
- 5.2. Gallstones
- 5.3. Global Gallbladder Treatment market by Gallstones, 2016-2026 (USD Billion)
- 5.4. Chulecystitis and Biliary Culic
- 5.4.1. Global Gallbladder Treatment market by Chulecystitis And Biliary Culic, 2016-2026 (USD Billion)
- 5.5. Chulelithiasis and Chuledochulithiasis
- 5.5.1. Global Gallbladder Treatment market by Chulelithiasis and Chuledochulithiasis, 2016-2026 (USD Billion)
- 5.6. Gallbladder Pulyps
- 5.6.1. Global Gallbladder Treatment market by Gallbladder Pulyps, 2016-2026 (USD Billion)
- 5.7. Gall Bladder Cancer
- 5.7.1. Global Gallbladder Treatment market by Gall Bladder Cancer, 2016-2026 (USD Billion)
- 5.1. Global Gallbladder Treatment market overview: by disease indications type
- Chapter 6. Global Gallbladder Treatment Market – Diagnosis Segment Analysis
- 6.1. Global Gallbladder Treatment market overview: by diagnosis
- 6.1.1. Global Gallbladder Treatment market revenue share, by diagnosis, 2019 and 2026
- 6.2. Growth Factors
- 6.2.1. Global Gallbladder Treatment market by Growth Factors, 2016-2026 (USD Billion)
- 6.3. Ultrasound
- 6.3.1. Global Gallbladder Treatment market by Ultrasound, 2016-2026 (USD Billion)
- 6.4. Blood Tests
- 6.4.1. Global Gallbladder Treatment market by Blood Tests, 2016-2026 (USD Billion)
- 6.5. Computerized Tomography (CT)
- 6.5.1. Global Gallbladder Treatment market by Computerized Tomography (CT), 2016-2026 (USD Billion)
- 6.6. Chulangiography
- 6.6.1. Global Gallbladder Treatment market by Chulangiography, 2016-2026 (USD Billion)
- 6.7. Hepatobiliary Scintigraphy
- 6.7.1. Global Gallbladder Treatment market by Hepatobiliary Scintigraphy, 2016-2026 (USD Billion)
- 6.1. Global Gallbladder Treatment market overview: by diagnosis
- Chapter 7. Global Gallbladder Treatment Market – Treatment Segment Analysis
- 7.1. Global Gallbladder Treatment market overview: by treatment
- 7.1.1. Global Gallbladder Treatment market revenue share, by treatment, 2019 and 2026
- 7.2. Surgery
- 7.2.1. Global Gallbladder Treatment market by Surgery, 2016-2026 (USD Billion)
- 7.3. Drugs
- 7.3.1. Global Gallbladder Treatment market by Drugs, 2016-2026 (USD Billion)
- 7.1. Global Gallbladder Treatment market overview: by treatment
- Chapter 8. Global Gallbladder Treatment Market – End Users Segment Analysis
- 8.1. Global Gallbladder Treatment market overview: by end users
- 8.1.1. Global Gallbladder Treatment market revenue share, by end users, 2019 and 2026
- 8.2. Hospitals & Gyneculogy Clinics
- 8.2.1. Global Gallbladder Treatment market by hospitals & gyneculogy clinics, 2016-2026 (USD Billion)
- 8.3. Academic & Research Centers
- 8.3.1. Global Gallbladder Treatment market by Academic & Research Centers, 2016-2026 (USD Billion)
- 8.1. Global Gallbladder Treatment market overview: by end users
- Chapter 9. Global Gallbladder Treatment Market - Regional Analysis
- 9.1. Global Gallbladder Treatment market overview: by region
- 9.1.1. Global Gallbladder Treatment market revenue share, by region, 2019 and 2026
- 9.2. North America
- 9.2.1. North America Gallbladder Treatment market, by country, 2016-2026 (USD Billion)
- 9.2.2. North America Gallbladder Treatment market revenue, by disease indications type, 2016-2026 (USD Billion)
- 9.2.3. North America Gallbladder Treatment market revenue, by diagnosis, 2016-2026 (USD Billion)
- 9.2.4. North America Gallbladder Treatment market revenue, by treatment, 2016-2026 (USD Billion)
- 9.2.5. North America Gallbladder Treatment market revenue, by end users, 2016-2026 (USD Billion)
- 9.2.6. The U.S.
- 9.2.6.1. The U.S. Gallbladder Treatment market revenue, by disease indications type, 2016-2026 (USD Billion)
- 9.2.6.2. The U.S. Gallbladder Treatment market revenue, by diagnosis, 2016-2026 (USD Billion)
- 9.2.6.3. The U.S. Gallbladder Treatment market revenue, by treatment, 2016-2026 (USD Billion)
- 9.2.6.4. The U.S. Gallbladder Treatment market revenue, by end users, 2016-2026 (USD Billion)
- 9.2.7. Rest of North America
- 9.2.7.1. Rest of North America Gallbladder Treatment market revenue, by disease indications type, 2016-2026 (USD Billion)
- 9.2.7.2. Rest of North America Gallbladder Treatment market revenue, by diagnosis, 2016-2026 (USD Billion)
- 9.2.7.3. Rest of North America Gallbladder Treatment market revenue, by treatment, 2016-2026 (USD Billion)
- 9.2.7.4. Rest of North America Gallbladder Treatment market revenue, by end users, 2016-2026 (USD Billion)
- 9.3. Europe
- 9.3.1. Europe Gallbladder Treatment market, by country, 2016-2026 (USD Billion)
- 9.3.2. Europe Gallbladder Treatment market revenue, by disease indications type, 2016-2026 (USD Billion)
- 9.3.3. Europe Gallbladder Treatment market revenue, by diagnosis, 2016-2026 (USD Billion)
- 9.3.4. Europe Gallbladder Treatment market revenue, by treatment, 2016-2026 (USD Billion)
- 9.3.5. Europe Gallbladder Treatment market revenue, by end users, 2016-2026 (USD Billion)
- 9.3.6. U.K.
- 9.3.6.1. U.K. Gallbladder Treatment market revenue, by disease indications type, 2016-2026 (USD Billion)
- 9.3.6.2. U.K. Gallbladder Treatment market revenue, by diagnosis, 2016-2026 (USD Billion)
- 9.3.6.3. U.K. Gallbladder Treatment market revenue, by treatment, 2016-2026 (USD Billion)
- 9.3.6.4. U.K. Gallbladder Treatment market revenue, by end users, 2016-2026 (USD Billion)
- 9.3.7. France
- 9.3.7.1. France Gallbladder Treatment market revenue, by disease indications type, 2016-2026 (USD Billion)
- 9.3.7.2. France Gallbladder Treatment market revenue, by diagnosis, 2016-2026 (USD Billion)
- 9.3.7.3. France Gallbladder Treatment market revenue, by treatment, 2016-2026 (USD Billion)
- 9.3.7.4. France Gallbladder Treatment market revenue, by end users, 2016-2026 (USD Billion)
- 9.3.8. Germany
- 9.3.8.1. Germany Gallbladder Treatment market revenue, by disease indications type, 2016-2026 (USD Billion)
- 9.3.8.2. Germany Gallbladder Treatment market revenue, by diagnosis, 2016-2026 (USD Billion)
- 9.3.8.3. Germany Gallbladder Treatment market revenue, by treatment, 2016-2026 (USD Billion)
- 9.3.8.4. Germany Gallbladder Treatment market revenue, by end users, 2016-2026 (USD Billion)
- 9.3.9. Rest of Europe
- 9.3.9.1. Rest of Europe Gallbladder Treatment market revenue, by disease indications type, 2016-2026 (USD Billion)
- 9.3.9.2. Rest of Europe Gallbladder Treatment market revenue, by diagnosis, 2016-2026 (USD Billion)
- 9.3.9.3. Rest of Europe Gallbladder Treatment market revenue, by treatment, 2016-2026 (USD Billion)
- 9.3.9.4. Rest of Europe Gallbladder Treatment market revenue, by end users, 2016-2026 (USD Billion)
- 9.4. Asia Pacific
- 9.4.1. Asia Pacific Gallbladder Treatment market, by country, 2016-2026 (USD Billion)
- 9.4.2. Asia Pacific Gallbladder Treatment market revenue, by disease indications type, 2016-2026 (USD Billion)
- 9.4.3. Asia Pacific Gallbladder Treatment market revenue, by diagnosis, 2016-2026 (USD Billion)
- 9.4.4. Asia Pacific Gallbladder Treatment market revenue, by treatment, 2016-2026 (USD Billion)
- 9.4.5. Asia Pacific Gallbladder Treatment market revenue, by end users, 2016-2026 (USD Billion)
- 9.4.6. China
- 9.4.6.1. China Gallbladder Treatment market revenue, by disease indications type, 2016-2026 (USD Billion)
- 9.4.6.2. China Gallbladder Treatment market revenue, by diagnosis, 2016-2026 (USD Billion)
- 9.4.6.3. China Gallbladder Treatment market revenue, by treatment, 2016-2026 (USD Billion)
- 9.4.6.4. China Gallbladder Treatment market revenue, by end users, 2016-2026 (USD Billion)
- 9.4.7. Japan
- 9.4.7.1. Japan Gallbladder Treatment market revenue, by disease indications type, 2016-2026 (USD Billion)
- 9.4.7.2. Japan Gallbladder Treatment market revenue, by diagnosis, 2016-2026 (USD Billion)
- 9.4.7.3. Japan Gallbladder Treatment market revenue, by treatment, 2016-2026 (USD Billion)
- 9.4.7.4. Japan Gallbladder Treatment market revenue, by end users, 2016-2026 (USD Billion)
- 9.4.8. India
- 9.4.8.1. India Gallbladder Treatment market revenue, by disease indications type, 2016-2026 (USD Billion)
- 9.4.8.2. India Gallbladder Treatment market revenue, by diagnosis, 2016-2026 (USD Billion)
- 9.4.8.3. India Gallbladder Treatment market revenue, by treatment, 2016-2026 (USD Billion)
- 9.4.8.4. India Gallbladder Treatment market revenue, by end users, 2016-2026 (USD Billion)
- 9.4.9. Rest of Asia Pacific
- 9.4.9.1. Rest of Asia Pacific Gallbladder Treatment market revenue, by disease indications type, 2016-2026 (USD Billion)
- 9.4.9.2. Rest of Asia Pacific Gallbladder Treatment market revenue, by diagnosis, 2016-2026 (USD Billion)
- 9.4.9.3. Rest of Asia Pacific Gallbladder Treatment market revenue, by treatment, 2016-2026 (USD Billion)
- 9.4.9.4. Rest of Asia Pacific Gallbladder Treatment market revenue, by end users, 2016-2026 (USD Billion)
- 9.5. Latin America
- 9.5.1. Latin America Gallbladder Treatment market, by country, 2016-2026 (USD Billion)
- 9.5.2. Latin America Gallbladder Treatment market revenue, by disease indications type, 2016-2026 (USD Billion)
- 9.5.3. Latin America Gallbladder Treatment market revenue, by diagnosis, 2016-2026 (USD Billion)
- 9.5.4. Latin America Gallbladder Treatment market revenue, by treatment, 2016-2026 (USD Billion)
- 9.5.5. Latin America Gallbladder Treatment market revenue, by end users, 2016-2026 (USD Billion)
- 9.5.6. Brazil
- 9.5.6.1. Brazil Gallbladder Treatment market revenue, by disease indications type, 2016-2026 (USD Billion)
- 9.5.6.2. Brazil Gallbladder Treatment market revenue, by diagnosis, 2016-2026 (USD Billion)
- 9.5.6.3. Brazil Gallbladder Treatment market revenue, by treatment, 2016-2026 (USD Billion)
- 9.5.6.4. Brazil Gallbladder Treatment market revenue, by end users, 2016-2026 (USD Billion)
- 9.5.7. Rest of Latin America
- 9.5.7.1. Rest of Latin America Gallbladder Treatment market revenue, by disease indications type, 2016-2026 (USD Billion)
- 9.5.7.2. Rest of Latin America Gallbladder Treatment market revenue, by diagnosis, 2016-2026 (USD Billion)
- 9.5.7.3. Rest of Latin America Gallbladder Treatment market revenue, by treatment, 2016-2026 (USD Billion)
- 9.5.7.4. Rest of Latin America Gallbladder Treatment market revenue, by end users, 2016-2026 (USD Billion)
- 9.6. Middle East & Africa
- 9.6.1. Middle East & Africa Gallbladder Treatment market, 2016-2026 (USD Billion)
- 9.6.2. Middle East & Africa Gallbladder Treatment market revenue, by disease indications type, 2016-2026 (USD Billion)
- 9.6.3. Middle East & Africa Gallbladder Treatment market revenue, by diagnosis, 2016-2026 (USD Billion)
- 9.6.4. Middle East & Africa Gallbladder Treatment market revenue, by treatment, 2016-2026 (USD Billion)
- 9.6.5. Middle East & Africa Gallbladder Treatment market revenue, by end users, 2016-2026 (USD Billion)
- 9.1. Global Gallbladder Treatment market overview: by region
- Chapter 10. Company Profiles
- 10.1. Boston Scientific Corporation.
- 10.1.1. Overview
- 10.1.2. Financials
- 10.1.3. Product portfolio
- 10.1.4. Business Strategy
- 10.1.5. Recent Developments
- 10.2. Intuitive Surgical
- 10.2.1. Overview
- 10.2.2. Financials
- 10.2.3. Product portfolio
- 10.2.4. Business Strategy
- 10.2.5. Recent Developments
- 10.3. C. R. Bard, Inc.
- 10.3.1. Overview
- 10.3.2. Financials
- 10.3.3. Product portfolio
- 10.3.4. Business Strategy
- 10.3.5. Recent Developments
- 10.4. Dornier MedTech
- 10.4.1. Overview
- 10.4.2. Financials
- 10.4.3. Product portfolio
- 10.4.4. Business Strategy
- 10.4.5. Recent Developments
- 10.5. Koninklijke Philips N.V
- 10.5.1. Overview
- 10.5.2. Financials
- 10.5.3. Product portfolio
- 10.5.4. Business Strategy
- 10.5.5. Recent Developments
- 10.6. B. Braun Melsungen AG
- 10.6.1. Overview
- 10.6.2. Financials
- 10.6.3. Product portfolio
- 10.6.4. Business Strategy
- 10.6.5. Recent Developments
- 10.7. Sanofi
- 10.7.1. Overview
- 10.7.2. Financials
- 10.7.3. Product portfolio
- 10.7.4. Business Strategy
- 10.7.5. Recent Developments
- 10.8. Company 8
- 10.8.1. Overview
- 10.8.2. Financials
- 10.8.3. Product portfolio
- 10.8.4. Business Strategy
- 10.8.5. Recent Developments
- 10.9. Company 9.
- 10.9.1. Overview
- 10.9.2. Financials
- 10.9.3. Product portfolio
- 10.9.4. Business Strategy
- 10.9.5. Recent Developments
- 10.10. Company 10
- 10.10.1. Overview
- 10.10.2. Financials
- 10.10.3. Product portfolio
- 10.10.4. Business Strategy
- 10.10.5. Recent Developments
- 10.1. Boston Scientific Corporation.
